Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Department of Psychology, University of Kentucky, Lexington, KY, USA.
Neuropsychopharmacology. 2014 Mar;39(4):955-62. doi: 10.1038/npp.2013.295. Epub 2013 Oct 22.
Poor decision making and elevated risk taking, particularly during adolescence, have been strongly linked to drug use; however the causal relationships among these factors are not well understood. To address these relationships, a rat model (the Risky Decision-making Task; RDT) was used to determine whether individual differences in risk taking during adolescence predict later propensity for cocaine self-administration and/or whether cocaine self-administration causes alterations in risk taking. In addition, the RDT was used to determine how risk taking is modulated by dopamine signaling, particularly in the striatum. Results from these experiments indicated that greater risk taking during adolescence predicted greater intake of cocaine during acquisition of self-administration in adulthood, and that adult cocaine self-administration in turn caused elevated risk taking that was present following 6 weeks of abstinence. Greater adolescent risk taking was associated with lower striatal D2 receptor mRNA expression, and pharmacological activation of D2/3 receptors in the ventral, but not dorsal, striatum induced a decrease in risk taking. These findings indicate that the relationship between elevated risk taking and cocaine self-administration is bi-directional, and that low striatal D2 receptor expression may represent a predisposing factor for both maladaptive decision making and cocaine use. Furthermore, these findings suggest that striatal D2 receptors represent a therapeutic target for attenuating maladaptive decision making when choices include risk of adverse consequences.
决策能力差和冒险行为增加,特别是在青春期,与药物使用密切相关;然而,这些因素之间的因果关系尚不清楚。为了解决这些关系,使用了一种大鼠模型(冒险决策任务;RDT)来确定青春期冒险行为的个体差异是否预测后期可卡因自我给药的倾向,或者可卡因自我给药是否导致冒险行为的改变。此外,RDT 用于确定冒险行为如何被多巴胺信号调节,特别是在纹状体中。这些实验的结果表明,青春期冒险行为越大,在成年期自我给药获得期间摄入可卡因的量就越大,而成年期可卡因自我给药反过来又导致冒险行为增加,这种增加在 6 周的禁欲后仍然存在。青春期冒险行为越大,纹状体 D2 受体 mRNA 表达越低,而腹侧而非背侧纹状体中 D2/3 受体的药理学激活会导致冒险行为减少。这些发现表明,冒险行为增加与可卡因自我给药之间的关系是双向的,而纹状体 D2 受体表达降低可能是不良决策和可卡因使用的易感因素。此外,这些发现表明,纹状体 D2 受体代表了一种治疗靶点,可减轻包括不良后果风险的选择中的不良决策。